DIN 02279479 — APIDRA 100 UNIT
APIDRA is a solution of Insulin glulisine marketed by SANOFI-AVENTIS CANADA INC. The full Insulin glulisine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02279479
- Brand name
- APIDRA
- Active ingredient
- Insulin glulisine
- Strength
- 100 UNIT
- Dosage form
- SOLUTION
- Route
- SUBCUTANEOUS
- Manufacturer
- SANOFI-AVENTIS CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Rapid-acting recombinant human insulin analogue
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Insulin glulisine products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02279460 | APIDRA | 100 UNIT | SOLUTION | SANOFI-AVENTIS CANADA INC | MARKETED |
| 02294346 | APIDRA | 100 UNIT | SOLUTION | SANOFI-AVENTIS CANADA INC | MARKETED |